Company intelligence / Profile preview

Phoenix Biotechnology, Inc.

San Antonio, Texas, United Statesphoenixbiotechnology.com ↗

Ownership: Private
Employees: ~15
Development stage: Preclinical

Overview

Research suggests their oleandrin extract prevents key viruses from correctly forming their protective envelope, rendering virus progeny non-infective. They've also shown superior effects on innate immune functions for dermal allergic reactions in canine cells compared to oclacitinib.

Therapeutic areas: OncologyImmunologyNeurologyInfectious Diseases
Modalities: Natural product extractsNerium oleander extract (NOE)
Industry: Biotech

Drug pipeline

9 assets

nerium oleander extract

8 more assets in the full pipeline.

Request access →

Partnerships

Avila Herbals, LLC (manufacturing and R&D agreement)

Beyond the preview

Go deeper on Phoenix Biotechnology, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoenix Biotechnology, Inc..

Explore the full profile